Maloberti Renaud Bertrand 4
4 · ENDRA Life Sciences Inc. · Filed May 30, 2019
Insider Transaction Report
Form 4
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
- Award
Stock Options
2019-05-28+35,000→ 35,000 totalExercise: $1.04Exp: 2029-05-28→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]These Stock Options become exercisable in three equal annual installments beginning on May 28, 2020.